Common stock

CLEAR Announces an Increase to its Share Repurchase Authorization

Retrieved on: 
Thursday, March 21, 2024

NEW YORK, March 21, 2024 /PRNewswire/ -- Clear Secure, Inc. (NYSE: YOU) ("CLEAR" or the "Company") today announced that its Board of Directors (the "Board") authorized a $100 million increase to its existing Class A Common Stock share repurchase program.

Key Points: 
  • NEW YORK, March 21, 2024 /PRNewswire/ -- Clear Secure, Inc. (NYSE: YOU) ("CLEAR" or the "Company") today announced that its Board of Directors (the "Board") authorized a $100 million increase to its existing Class A Common Stock share repurchase program.
  • During the first quarter of 2024, the Company used $84.9 million to repurchase and retire 4.4 million shares of Class A Common Stock at an average price of $19.22.
  • Including the $100 million increase announced today, approximately $141 million in aggregate remains available under the repurchase authorization.
  • Year-to-date share repurchases, our regular dividend and today's special dividend announcement represent approximately $157 million already returned to shareholders in 2024," said Kenneth Cornick, CLEAR's President and Chief Financial Officer.

CLEAR Announces $0.32 Special Cash Dividend

Retrieved on: 
Thursday, March 21, 2024

NEW YORK, March 21, 2024 /PRNewswire/ -- Clear Secure, Inc. (NYSE: YOU) ("CLEAR" or the "Company") today announced the declaration of a special cash dividend in the amount of $0.32 per share payable on April 8, 2024 to holders of record of the Class A Common Stock and Class B Common Stock as of the close of business on April 1, 2024.

Key Points: 
  • NEW YORK, March 21, 2024 /PRNewswire/ -- Clear Secure, Inc. (NYSE: YOU) ("CLEAR" or the "Company") today announced the declaration of a special cash dividend in the amount of $0.32 per share payable on April 8, 2024 to holders of record of the Class A Common Stock and Class B Common Stock as of the close of business on April 1, 2024.
  • The Company is funding the payment of the special cash dividend with cash received from pro rata cash distributions made by Alclear Holdings, LLC to all of its members, including the Company.
  • The distributions consist of a mandatory tax distribution as well as a discretionary distribution.

Scholastic Appoints Alix Guerrier and Kaya Henderson to its Board of Directors

Retrieved on: 
Thursday, March 21, 2024

NEW YORK, March 21, 2024 /PRNewswire/ -- Scholastic (NASDAQ: SCHL), the global children's publishing, education and media company, today announced that Alix Guerrier and Kaya Henderson were appointed to its board of directors (the "Board") as independent directors, effective March 20, 2024.

Key Points: 
  • NEW YORK, March 21, 2024 /PRNewswire/ -- Scholastic (NASDAQ: SCHL), the global children's publishing, education and media company, today announced that Alix Guerrier and Kaya Henderson were appointed to its board of directors (the "Board") as independent directors, effective March 20, 2024.
  • Mr. Guerrier contributes over 20 years of experience in the education sector including as a teacher and an educational technology entrepreneur.
  • Ms. Henderson currently serves as Chief Executive Officer of Reconstruction US, a technology company she co-founded and launched in April 2020.
  • Before serving in her current role, Ms. Henderson served as Principal for her consulting company, Kaya Henderson Consulting.

Scholastic Corporation Announces Fourth Quarter Dividend

Retrieved on: 
Wednesday, March 20, 2024

NEW YORK, March 20, 2024 /PRNewswire/ -- Scholastic Corporation (NASDAQ: SCHL) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on the Company's Class A and Common Stock for the fourth quarter of fiscal 2024.

Key Points: 
  • NEW YORK, March 20, 2024 /PRNewswire/ -- Scholastic Corporation (NASDAQ: SCHL) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on the Company's Class A and Common Stock for the fourth quarter of fiscal 2024.
  • The dividend is payable on June 17, 2024, to all shareholders of record as of the close of business on April 30, 2024.

AMBASE REPORTS RESULTS FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2023

Retrieved on: 
Monday, March 18, 2024

The Company has been considering and evaluating various strategic funding and financing alternatives in order to raise capital.

Key Points: 
  • The Company has been considering and evaluating various strategic funding and financing alternatives in order to raise capital.
  • The Company expects to receive gross proceeds of approximately $8.8 million in connection with the Equity Offering before deducting offering expenses.
  • The information in this press release should be read in conjunction with the AmBase Corporation's Annual Report on Form 10-K for the year-to-date period ended December 31, 2023, filed with the Securities and Exchange Commission.
  • A more complete discussion of the Company's annual results and the Company's affairs is included in AmBase Corporation's Annual Report on 10-K for the annual period December 31, 2023, filed with the Securities and Exchange Commission.

Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders and New Record Date of Special Meeting of Stockholders

Retrieved on: 
Wednesday, March 13, 2024

You will need the 12-digit meeting control number that is printed on your proxy card to enter the Special Meeting.

Key Points: 
  • You will need the 12-digit meeting control number that is printed on your proxy card to enter the Special Meeting.
  • The record date for the Special Meeting will be March 13, 2024.
  • The previous submission of proxies also will not affect your right to vote in the event that you attend the Special Meeting.
  • Please note, however, that attendance alone at the Special Meeting without voting will not be sufficient to revoke a previously authorized proxy.

NEW YORK COMMUNITY BANCORP, INC. CLOSES OVER $1 BILLION EQUITY INVESTMENT STRENGTHENING BALANCE SHEET AND LIQUIDITY POSITION

Retrieved on: 
Tuesday, March 12, 2024

HICKSVILLE, N.Y., March 11, 2024 /PRNewswire/ -- New York Community Bancorp, Inc. (NYSE: NYCB) ("NYCB" or the "Company") announced today it completed the previously announced transactions resulting in individual investments aggregating to approximately $1.05 billion in the Company by Liberty Strategic Capital ("Liberty"), funds managed by Hudson Bay Capital Management ("Hudson Bay"), funds managed by Reverence Capital Partners ("Reverence Capital"), and other investors (collectively, the "Investors").

Key Points: 
  • Our Company enters this next phase with an enhanced balance sheet and liquidity position."
  • We believe that this transaction has strengthened the Company's balance sheet and liquidity position and look forward to working with management and the dedicated workforce of NYCB to deliver shareholder value."
  • Mr. DiNello, Marshall Lux, Lawrence Savarese, Peter Schoels, David Treadwell and Jennifer Whip remain members of the Board.
  • In addition, in connection with Reg Y Transfers, the Series C Preferred Stock is automatically convertible into 1,000 shares of our common stock.

Funding Circle Plc: Share Repurchase Programme

Retrieved on: 
Wednesday, March 13, 2024

Funding Circle Holdings plc (“Funding Circle”) announces a discretionary programme to purchase ordinary shares of £0.001 each in its share capital (the “Ordinary Shares”) up to a maximum consideration of £25 million (the “Programme”).

Key Points: 
  • Funding Circle Holdings plc (“Funding Circle”) announces a discretionary programme to purchase ordinary shares of £0.001 each in its share capital (the “Ordinary Shares”) up to a maximum consideration of £25 million (the “Programme”).
  • It is expected that, unless terminated earlier, the Programme will end on the date on which the total GBP purchase price of all Ordinary Shares purchased by Funding Circle pursuant to the Programme is equal to, or as close as possible to, £25 million.
  • The Company has appointed its broker, Numis Securities Limited (“Deutsche Numis”), to manage the share buyback programme to repurchase Ordinary Shares on its behalf.
  • Following the expiry of the 2023 AGM repurchase authority, or to the extent that Funding Circle meets the limit of that authority prior to the 2024 AGM, Funding Circle will seek further repurchase authority at the 2024 AGM or an earlier General Meeting.

NewLake Capital Partners Reports Fourth Quarter and Full-Year 2023 Financial Results; Raises First Quarter 2024 Common Stock Dividend to $0.41 per Share

Retrieved on: 
Monday, March 11, 2024

NEW CANAAN, Conn., March 11, 2024 (GLOBE NEWSWIRE) -- NewLake Capital Partners, Inc. (OCTQX: NLCP) (the “Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced its financial results for the fourth quarter and full year ended December 31, 2023, and declared its first quarter of 2024 dividend.

Key Points: 
  • Anthony Coniglio, President and Chief Executive Officer, said, “We are pleased to deliver solid fourth quarter and full year financial results.
  • Declared a fourth quarter dividend of $0.40 per share of common stock, an increase of 2.6% year-over-year.
  • For the twelve months ended December 31, 2023, the Company declared dividends of $1.57 per share of common stock, an increase of 9.0% year-over-year.
  • The following tables present the Company’s investment activity for the twelve months ended December 31, 2023 (dollars in thousands):

Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing

Retrieved on: 
Monday, March 11, 2024

Lexeo anticipates the gross proceeds from the private placement to be approximately $95.0 million, before deducting any offering related expenses.

Key Points: 
  • Lexeo anticipates the gross proceeds from the private placement to be approximately $95.0 million, before deducting any offering related expenses.
  • The financing is expected to close on March 13, 2024, subject to customary closing conditions.
  • Lexeo intends to use net proceeds from the financing to fund advancement of ongoing clinical stage programs, and for working capital and general corporate purposes.
  • The proceeds from this financing, combined with current cash, cash equivalents and marketable securities are expected to fund Lexeo’s operating and capital expenditures into 2027.